The NASH phase 2 results were great, not average, marketing will come online soon, they have the US department of defence report on travelans "strong reactivity to 60 clinical isolates of personnel infected with ETEC and 60 personnel infected with Shigella" which will make a great marketing campaign for travelan 2018. The week has been a bad one for most of the market with Trumps comments and trade war fears. I am still 30% ahead on my holdings. I expect to be 100 % ahead before too long but not panicky because this is a keeper.
IMC Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
